(Q39523783)

12 September 2017

title

Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer (English)

1 reference

12 September 2017

0 references

5

Elke Jäger

1 reference

12 September 2017

Akin Atmaca

1

1 reference

12 September 2017

Claudia Pauligk

2

1 reference

12 September 2017

Kristina Steinmetz

3

1 reference

12 September 2017

Hans-Michael Altmannsberger

4

1 reference

12 September 2017

Salah-Eddin Al-Batran

6

1 reference

12 September 2017

publication date

14 June 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

80

1 reference

12 September 2017

issue

1-2

1 reference

12 September 2017

page(s)

130-134

1 reference

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

12 September 2017

cites work

1 reference

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

21 January 2018

1 reference

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

21 January 2018

1 reference

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie

21 January 2018

1 reference

Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.

21 January 2018

1 reference

Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

21 January 2018

1 reference

Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma

21 January 2018

1 reference

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers

21 January 2018

1 reference

Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000329063

1 reference

12 September 2017

1 reference